GSK's liquid meningitis vaccine ... phase three--determine how well a drug works in subjects at a given dose to assess their efficacy. The original presentation of Menveo that requires reconstitution, ...

JPMorgan lowered the firm’s price target on Moderna (MRNA) to $45 from $59 and keeps an Underweight rating on the shares. The firm updated ...

The Food and Drug Administration (FDA) has approved Zurnai ™, the first nalmefene HCl autoinjector for the emergency treatment of known or suspected opioid overdose in adults an ...

The presumptive new CDC director, Dave Weldon, is a known vaccine safety skeptic. In contrast, the FDA choice — Johns Hopkins ...

Trump’s picks, made late Friday, did little to dispel the notion that the nation’s federal health agencies are facing a major ...

Marty Makary, an outspoken critic of the nation’s food and drug regulator, stands to shake up the FDA’s standards in science ...

Makary and Weldon, who have criticized the agencies they may soon run, were joined by Janette Nesheiwat, Trump’s pick to be ...

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to ...

President-elect Donald Trump has nominated a critic of COVID-19 health measures to lead the Food and Drug Administration.

Moderna shares surged further Friday, a day after a senior executive made bullish comments at a healthcare conference about the vaccine maker's pipeline and cash position.

Moderna, Inc.'s stock plummets as challenges mount, including vaccine skepticism, competitive pressures, and the RFK ...

As the biopharma industry braces for a second term under President-elect Donald Trump, speculation is swirling around the ...